Su X - Search Results

1

Synuclein activates microglia in a model of Parkinson's disease.

Su X, Maguire-Zeiss KA, Giuliano R, Prifti L, Venkatesh K, Federoff HJ. Su X, et al. Neurobiol Aging. 2008 Nov;29(11):1690-701. doi: 10.1016/j.neurobiolaging.2007.04.006. Epub 2007 May 29. Neurobiol Aging. 2008. PMID: 17537546 Free PMC article.

2

Mutant alpha-synuclein overexpression mediates early proinflammatory activity.

Su X, Federoff HJ, Maguire-Zeiss KA. Su X, et al. Neurotox Res. 2009 Oct;16(3):238-54. doi: 10.1007/s12640-009-9053-x. Epub 2009 Apr 28. Neurotox Res. 2009. PMID: 19526281 Free PMC article.

3

Identification of human alpha-synuclein specific single chain antibodies.

Maguire-Zeiss KA, Wang CI, Yehling E, Sullivan MA, Short DW, Su X, Gouzer G, Henricksen LA, Wuertzer CA, Federoff HJ. Maguire-Zeiss KA, et al. Among authors: su x. Biochem Biophys Res Commun. 2006 Nov 3;349(4):1198-205. doi: 10.1016/j.bbrc.2006.08.127. Epub 2006 Aug 30. Biochem Biophys Res Commun. 2006. PMID: 16973126

4

Human interleukin-10 gene transfer is protective in a rat model of Parkinson's disease.

Johnston LC, Su X, Maguire-Zeiss K, Horovitz K, Ankoudinova I, Guschin D, Hadaczek P, Federoff HJ, Bankiewicz K, Forsayeth J. Johnston LC, et al. Among authors: su x. Mol Ther. 2008 Aug;16(8):1392-9. doi: 10.1038/mt.2008.113. Epub 2008 Jun 10. Mol Ther. 2008. PMID: 18545225 Free PMC article.

5

PGC-1α Promoter Methylation in Parkinson's Disease.

Su X, Chu Y, Kordower JH, Li B, Cao H, Huang L, Nishida M, Song L, Wang D, Federoff HJ. Su X, et al. PLoS One. 2015 Aug 28;10(8):e0134087. doi: 10.1371/journal.pone.0134087. eCollection 2015. PLoS One. 2015. PMID: 26317511 Free PMC article.

6

Immune responses in Parkinson's disease: interplay between central and peripheral immune systems.

Su X, Federoff HJ. Su X, et al. Biomed Res Int. 2014;2014:275178. doi: 10.1155/2014/275178. Epub 2014 Apr 13. Biomed Res Int. 2014. PMID: 24822191 Free PMC article. Review.

7

Development of inducible leucine-rich repeat kinase 2 (LRRK2) cell lines for therapeutics development in Parkinson's disease.

Huang L, Shimoji M, Wang J, Shah S, Kamila S, Biehl ER, Lim S, Chang A, Maguire-Zeiss KA, Su X, Federoff HJ. Huang L, et al. Among authors: su x. Neurotherapeutics. 2013 Oct;10(4):840-51. doi: 10.1007/s13311-013-0208-3. Neurotherapeutics. 2013. PMID: 23963789 Free PMC article.

8

Alpha-Synuclein mRNA Is Not Increased in Sporadic PD and Alpha-Synuclein Accumulation Does Not Block GDNF Signaling in Parkinson's Disease and Disease Models.

Su X, Fischer DL, Li X, Bankiewicz K, Sortwell CE, Federoff HJ. Su X, et al. Mol Ther. 2017 Oct 4;25(10):2231-2235. doi: 10.1016/j.ymthe.2017.04.018. Epub 2017 May 15. Mol Ther. 2017. PMID: 28522034 Free PMC article. No abstract available.

9

Regeneration of the MPTP-lesioned dopaminergic system after convection-enhanced delivery of AAV2-GDNF.

Kells AP, Eberling J, Su X, Pivirotto P, Bringas J, Hadaczek P, Narrow WC, Bowers WJ, Federoff HJ, Forsayeth J, Bankiewicz KS. Kells AP, et al. Among authors: su x. J Neurosci. 2010 Jul 14;30(28):9567-77. doi: 10.1523/JNEUROSCI.0942-10.2010. J Neurosci. 2010. PMID: 20631185 Free PMC article.

10

Single-chain fragment variable passive immunotherapies for neurodegenerative diseases.

Huang L, Su X, Federoff HJ. Huang L, et al. Among authors: su x. Int J Mol Sci. 2013 Sep 17;14(9):19109-27. doi: 10.3390/ijms140919109. Int J Mol Sci. 2013. PMID: 24048248 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,565 results

Search Page

Filters